NCT00497991 - Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

April 30, 2010

Conditions

Myeloid Leukemia

Interventions

DRUG

AZD1152

Trial Locations (10)

Research Site, New York

Research Site, Houston

Research Site, Angers

Research Site, Grenoble

Research Site, Le Chesnay

Research Site, Bologna

Research Site, Roma

Research Site, Amsterdam

Research Site, Nijmegen

Research Site, Rotterdam